What we strive for
We bring new value to human health by untrapping the potential of known molecular entities. We are passionate about accelerated drug development pathways that can deliver quality of life to patients with unmet needs. As a Swiss-based drug development company, OrchestratePharma is located in a hub of global pharma leadership and research.
Our first drug in clinical development is FexoTopic (OP2101). With FexoTopic we strive to deliver a safe, effective and economical treatment for children and adults with Atopic Dermatitis, also called Eczema. FexoTopic is envisaged as an "Eczema Ease & Prevent" lotion for fast itch-relief and long-term eczema flare-up prevention. A main objective is to attain a pleasant skin-feel when applied to the sensitive skin of an atopic child. FexoTopic represents our passion to provide safe and effective medicines affecting the quality of life especially in children.
